Tarsus Pharmaceuticals Statistics
Total Valuation
TARS has a market cap or net worth of $3.96 billion. The enterprise value is $3.74 billion.
| Market Cap | 3.96B |
| Enterprise Value | 3.74B |
Important Dates
The last earnings date was Tuesday, November 3, 2026, after market close.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TARS has 49.31 million shares outstanding. The number of shares has increased by 7.76% in one year.
| Current Share Class | 49.31M |
| Shares Outstanding | 49.31M |
| Shares Change (YoY) | +7.76% |
| Shares Change (QoQ) | +6.98% |
| Owned by Insiders (%) | 2.75% |
| Owned by Institutions (%) | 84.04% |
| Float | 38.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.80 |
| Forward PS | 4.47 |
| PB Ratio | 38.05 |
| P/TBV Ratio | 45.30 |
| P/FCF Ratio | 122.01 |
| P/OCF Ratio | 79.33 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 115.23 |
Financial Position
The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.86.
| Current Ratio | 1.96 |
| Quick Ratio | 1.81 |
| Debt / Equity | 0.86 |
| Debt / EBITDA | n/a |
| Debt / FCF | 2.76 |
| Interest Coverage | -7.55 |
Financial Efficiency
Return on equity (ROE) is -319.84% and return on invested capital (ROIC) is -13.41%.
| Return on Equity (ROE) | -319.84% |
| Return on Assets (ROA) | -7.88% |
| Return on Invested Capital (ROIC) | -13.41% |
| Return on Capital Employed (ROCE) | -23.54% |
| Weighted Average Cost of Capital (WACC) | 6.11% |
| Revenue Per Employee | $1.84M |
| Profits Per Employee | -$1.90M |
| Employee Count | 370 |
| Asset Turnover | 1.31 |
| Inventory Turnover | 24.60 |
Taxes
In the past 12 months, TARS has paid $11.77 million in taxes.
| Income Tax | 11.77M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.31% in the last 52 weeks. The beta is 0.33, so TARS's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +7.31% |
| 50-Day Moving Average | 74.85 |
| 200-Day Moving Average | 67.97 |
| Relative Strength Index (RSI) | 64.82 |
| Average Volume (20 Days) | 861,583 |
Short Selling Information
The latest short interest is 6.07 million, so 12.30% of the outstanding shares have been sold short.
| Short Interest | 6.07M |
| Short Previous Month | 5.73M |
| Short % of Shares Out | 12.30% |
| Short % of Float | 15.90% |
| Short Ratio (days to cover) | 6.22 |
Income Statement
In the last 12 months, TARS had revenue of $682.20 million and -$702.23 million in losses. Loss per share was -$16.00.
| Revenue | 682.20M |
| Gross Profit | 571.55M |
| Operating Income | -65.54M |
| Pretax Income | -690.46M |
| Net Income | -702.23M |
| EBITDA | -62.64M |
| EBIT | -65.54M |
| Loss Per Share | -$16.00 |
Balance Sheet
The company has $309.61 million in cash and $89.43 million in debt, with a net cash position of $220.18 million or $4.47 per share.
| Cash & Cash Equivalents | 309.61M |
| Total Debt | 89.43M |
| Net Cash | 220.18M |
| Net Cash Per Share | $4.47 |
| Equity (Book Value) | 104.03M |
| Book Value Per Share | 2.11 |
| Working Capital | 218.30M |
Cash Flow
In the last 12 months, operating cash flow was $49.90 million and capital expenditures -$17.46 million, giving a free cash flow of $32.44 million.
| Operating Cash Flow | 49.90M |
| Capital Expenditures | -17.46M |
| Depreciation & Amortization | 2.91M |
| Net Borrowing | n/a |
| Free Cash Flow | 32.44M |
| FCF Per Share | $0.66 |
Margins
Gross margin is 83.78%, with operating and profit margins of -9.61% and -102.93%.
| Gross Margin | 83.78% |
| Operating Margin | -9.61% |
| Pretax Margin | -101.21% |
| Profit Margin | -102.93% |
| EBITDA Margin | -9.18% |
| EBIT Margin | -9.61% |
| FCF Margin | 4.76% |
Dividends & Yields
TARS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -7.76% |
| Shareholder Yield | -7.76% |
| Earnings Yield | -19.93% |
| FCF Yield | 0.82% |
Analyst Forecast
The average price target for TARS is $103.44, which is 28.85% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $103.44 |
| Price Target Difference | 28.85% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 36.86% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TARS has an Altman Z-Score of 2.79 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.79 |
| Piotroski F-Score | 3 |